A new short paper of interest (to me) amongst all of the tweets.
Midkine, a middle manager of ß2 integrins
by M. Herter and Tanya N. Mayadas
the authors are getting to the heart of midkine's signalling / inflammation role which mobilises certain white blood cell cells (neutrophils)to the site of a trauma.
The authors conclude:
"In summary, Weckbach et al have provided
a molecular mechanism for the observed
requirement for MK in leukocyte extravasation
in many in?ammation models. The speci?c
function of MK for a discrete process in
leukocyte recruitment and its extracellular
accessibility make it an IDEAL TARGET FOR PHARMACOLOGIC INTERVENTION." [my capitalisations]
This is coming from Harvard Medical School and the authors declare not conflict of interest.
cheers
- Forums
- ASX - By Stock
- pipeline update
A new short paper of interest (to me) amongst all of the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
AN1 (ASX) Chart |
Day chart unavailable